{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:13:33Z","timestamp":1791810813405,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T00:00:00Z","timestamp":1701475200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.molmet.2023.101850","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T03:04:42Z","timestamp":1701918282000},"page":"101850","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Evaluation of long acting GLP1R\/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1\/glucagon agonism in NASH patients"],"prefix":"10.1016","volume":"79","author":[{"given":"Thomas","family":"Monfeuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Norlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Bugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth D.","family":"Gaalsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar A.","family":"Prada-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Latta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne S.","family":"Veidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia S.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Feigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2777-6845","authenticated-orcid":false,"given":"Dorte","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmet.2023.101850_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fmed.2020.00467","article-title":"Disturbances in cholesterol homeostasis and non-alcoholic fatty liver diseases","volume":"7","author":"Malhotra","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.molmet.2023.101850_bib2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2023.101850_bib3","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.14309\/ajg.0000000000000375","article-title":"Patients with nonalcoholic steatohepatitis experience severe impairment of health-related quality of life","volume":"114","author":"Younossi","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101850_bib4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.molmet.2023.101850_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.metabol.2015.08.018","article-title":"Genetics of nonalcoholic fatty liver disease","volume":"65","author":"Dongiovanni","year":"2016","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.molmet.2023.101850_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101850_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.molmet.2023.101850_bib8","first-page":"e6","article-title":"Semaglutide or placebo for nonalcoholic steatohepatitis. Reply","volume":"385","author":"Newsome","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.molmet.2023.101850_bib9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/phar.2534","article-title":"Glucagon: its evolving role in the management of hypoglycemia","volume":"41","author":"Isaacs","year":"2021","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.molmet.2023.101850_bib10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/13543784.2017.1395020","article-title":"Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes","volume":"26","author":"Scheen","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"issue":"11","key":"10.1016\/j.molmet.2023.101850_bib11","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/dom.12958","article-title":"Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes","volume":"19","author":"Guzman","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"10.1016\/j.molmet.2023.101850_bib12","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/dom.12735","article-title":"Robust anti-obesity and metabolic effects of a dual GLP-1\/glucagon receptor peptide agonist in rodents and non-human primates","volume":"18","author":"Henderson","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.molmet.2023.101850_bib13","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.28962","article-title":"A\u00a0novel glucagon-like peptide 1\/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice","volume":"65","author":"Valdecantos","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.molmet.2023.101850_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264974","article-title":"Preclinical evaluation of a protracted GLP-1\/glucagon receptor co-agonist: translational difficulties and pitfalls","volume":"17","author":"Simonsen","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2023.101850_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101633","article-title":"BI 456906: discovery and preclinical pharmacology of a novel GCGR\/GLP-1R dual agonist with robust anti-obesity efficacy","volume":"66","author":"Zimmermann","year":"2022","journal-title":"Mol Metab"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2023.101850_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0167-0115(88)90099-7","article-title":"Oxyntomodulin (glicentin-(33-69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs","volume":"21","author":"Baldissera","year":"1988","journal-title":"Regul Pept"},{"issue":"8","key":"10.1016\/j.molmet.2023.101850_bib17","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/diabetes.54.8.2390","article-title":"Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial","volume":"54","author":"Wynne","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2023.101850_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.735019","article-title":"Striking the balance: GLP-1\/glucagon co-agonism as a treatment strategy for obesity","volume":"12","author":"Hope","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10140","key":"10.1016\/j.molmet.2023.101850_bib19","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/S0140-6736(18)30726-8","article-title":"MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study","volume":"391","author":"Ambery","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.molmet.2023.101850_bib20","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/dc20-2151","article-title":"Effects of cotadutide on metabolic and hepatic parameters in adults with overweight or obesity and type 2 diabetes: a 54-week randomized phase 2b study","volume":"44","author":"Nahra","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.molmet.2023.101850_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3748\/wjg.v24.i2.179","article-title":"Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis","volume":"24","author":"Tolbol","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101850_bib22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12876-020-01356-2","article-title":"Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis","volume":"20","author":"Hansen","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101850_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48746-5","article-title":"Gene expression predicts histological severity and reveals distinct molecular profiles of nonalcoholic fatty liver disease","volume":"9","author":"Hoang","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.molmet.2023.101850_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96966-5","article-title":"Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD","volume":"11","author":"Pantano","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molmet.2023.101850_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat Methods"},{"issue":"19","key":"10.1016\/j.molmet.2023.101850_bib26","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.molmet.2023.101850_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007664","article-title":"Tximeta: reference sequence checksums for provenance identification in RNA-seq","volume":"16","author":"Love","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"10.1016\/j.molmet.2023.101850_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"5","key":"10.1016\/j.molmet.2023.101850_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.molmet.2023.101850_bib30","series-title":"The igraph software package for complex network research","author":"Cs\u00e1rdi","year":"2006"},{"key":"10.1016\/j.molmet.2023.101850_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.molmet.2023.101850_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.molmet.2023.101850_bib33","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Softw"},{"key":"10.1016\/j.molmet.2023.101850_bib34","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2164-10-22","article-title":"BioMart--biological queries made easy","volume":"10","author":"Smedley","year":"2009","journal-title":"BMC Genomics"},{"issue":"D1","key":"10.1016\/j.molmet.2023.101850_bib35","doi-asserted-by":"crossref","first-page":"D884","DOI":"10.1093\/nar\/gkaa942","article-title":"Ensembl 2021","volume":"49","author":"Howe","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.molmet.2023.101850_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.cmi.2016.09.017","article-title":"Role of assessing liver fibrosis in management of chronic hepatitis C virus infection","volume":"22","author":"Carmona","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"18","key":"10.1016\/j.molmet.2023.101850_bib37","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.molmet.2023.101850_bib38","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2468-1253(23)00068-7","article-title":"Semaglutide 2.4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial","volume":"8","author":"Loomba","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.molmet.2023.101850_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-2007-1018747","article-title":"Effects of glucagon on basal metabolic rate and oxidative phosphorylation of rat liver mitochondria","volume":"15","author":"Breton","year":"1983","journal-title":"Horm Metab Res"},{"issue":"Pt 2","key":"10.1016\/j.molmet.2023.101850_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1042\/BST0340213","article-title":"Regulation of protein synthesis by insulin","volume":"34","author":"Proud","year":"2006","journal-title":"Biochem Soc Trans"},{"issue":"5","key":"10.1016\/j.molmet.2023.101850_bib41","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/ajcn\/73.5.878","article-title":"Effects of isoenergetic high-carbohydrate compared with high-fat diets on human cholesterol synthesis and expression of key regulatory genes of cholesterol metabolism","volume":"73","author":"Vidon","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.molmet.2023.101850_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-018-0791-z","article-title":"Does glucagon have a positive inotropic effect in the human heart?","volume":"17","author":"Hernandez-Cascales","year":"2018","journal-title":"Cardiovasc Diabetol"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:36:52Z","timestamp":1761957412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823001849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":42,"alternative-id":["S2212877823001849"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101850","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of long acting GLP1R\/GCGR agonist in a DIO and biopsy-confirmed mouse model of NASH suggest a beneficial role of GLP-1\/glucagon agonism in NASH patients","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101850","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101850"}}